Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
Divi's Laboratories (DIVI IN)
Watchlist
102
Analysis
Health Care
•
India
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
NIFTY Index
•
04 Oct 2024 23:00
EQD | Is the NIFTY A BUY Here?
The NIFTY Index closed the week down, now the question is: IS THIS A GOOD TIME TO (RE)ENTER LONG? As always, the Market Reversal Matrix models...
Nico Rosti
Follow
662 Views
Share
bearish
•
NTPC Ltd
•
26 Sep 2024 01:54
NIFTY Indices: Flows (Post Capping) At the Close Tomorrow; Round-Trip US$3.3bn
The next rebalance of the Nifty family of indices takes place at the close on 27 Sep. The round-trip trade is US$3.3bn and there are 13 stocks with...
Brian Freitas
Follow
614 Views
Share
bullish
•
Bharat Heavy Electricals
•
25 Aug 2024 21:50
NIFTY NEXT50 Index Rebalance: 7 Changes on Expected Lines
There are 7 changes for the NIFTY Next50 Index. Estimated 1-way turnover is 19.6% resulting in a 1-way trade of INR 63.64bn (US$759m). There are...
Brian Freitas
Follow
643 Views
Share
bullish
•
Trent Ltd
•
25 Aug 2024 00:00
NIFTY50 Index Rebalance: Trent, BEL to Replace Divi's Lab, LTIMindtree
Trent and Bharat Electronics will replace LTIM and Divi Lab in the NIFTY50. There is over 5x ADV/11x delivery volume to trade in the stocks. There...
Brian Freitas
Follow
564 Views
Share
bullish
•
Dr. Reddy's Laboratories
•
20 Aug 2024 08:42
Quiddity Leaderboard NIFTY Sep 24: Final Expectations; Trades Perform Positively; New Ideas
The official index changes for the NIFTY September 2024 index rebal event will be confirmed after market close on Friday 23rd August 2024. In this...
Janaghan Jeyakumar, CFA
Follow
738 Views
Share
First
Previous
5
6
7
8
9
10
11
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x